Molina Healthcare’s (MOH) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Molina Healthcare (NYSE:MOH) in a research report sent to investors on Monday morning, Benzinga reports. The firm currently has a $406.00 target price on the stock.

Several other analysts have also weighed in on the company. Stephens restated an equal weight rating and set a $320.00 price target on shares of Molina Healthcare in a report on Thursday, July 25th. Truist Financial dropped their price target on shares of Molina Healthcare from $440.00 to $400.00 and set a buy rating for the company in a research note on Monday, July 15th. Wells Fargo & Company increased their price objective on shares of Molina Healthcare from $315.00 to $360.00 and gave the stock an equal weight rating in a research report on Monday, August 5th. Baird R W upgraded Molina Healthcare to a strong-buy rating in a research report on Thursday, May 30th. Finally, Barclays reduced their target price on Molina Healthcare from $437.00 to $430.00 and set an equal weight rating on the stock in a research note on Thursday, April 25th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of Moderate Buy and a consensus price target of $378.00.

Molina Healthcare Price Performance

Molina Healthcare stock opened at $344.34 on Monday. Molina Healthcare has a 52-week low of $282.96 and a 52-week high of $423.92. The company has a market cap of $20.18 billion, a price-to-earnings ratio of 18.68, a PEG ratio of 1.20 and a beta of 0.58. The firm’s fifty day moving average is $315.73 and its 200 day moving average is $349.96. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The firm had revenue of $9.88 billion during the quarter, compared to the consensus estimate of $9.75 billion. During the same quarter last year, the firm earned $5.65 EPS. The firm’s revenue for the quarter was up 18.7% compared to the same quarter last year. Sell-side analysts forecast that Molina Healthcare will post 23.5 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Trading of Molina Healthcare

Large investors have recently bought and sold shares of the stock. Cetera Investment Advisers lifted its stake in shares of Molina Healthcare by 516.4% during the first quarter. Cetera Investment Advisers now owns 10,238 shares of the company’s stock worth $4,206,000 after buying an additional 8,577 shares during the period. BlackBarn Capital Partners LP acquired a new stake in Molina Healthcare during the 4th quarter worth about $15,139,000. BI Asset Management Fondsmaeglerselskab A S grew its stake in Molina Healthcare by 69.5% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 11,809 shares of the company’s stock valued at $4,851,000 after purchasing an additional 4,840 shares during the last quarter. Overbrook Management Corp increased its holdings in shares of Molina Healthcare by 1.1% in the fourth quarter. Overbrook Management Corp now owns 36,908 shares of the company’s stock valued at $13,335,000 after purchasing an additional 391 shares during the period. Finally, Nomura Asset Management Co. Ltd. raised its stake in shares of Molina Healthcare by 76.4% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 27,301 shares of the company’s stock worth $9,864,000 after purchasing an additional 11,820 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.